Johnson & Johnson Anticipates Covid Vaccine Sales of $2.5 Billion in 2021
July 21 2021 - 9:56AM
ValueWalk
Johnson & Johnson (NYSE:JNJ) is expecting its COVID-19 vaccine
to reach $2.5 billion in sales this year, despite concerns about
the injection’s efficacy against the dreaded Delta variant. [soros]
Q2 2021 hedge fund letters, conferences and more Second Quarter
Results On Wednesday, the company released its financial results
for the second quarter, beating Wall Street […]
https://www.valuewalk.com/jj-covid-vaccine-sales-2-5-billion-2021/
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024